The mechanism depends entirely on the dosing pattern
Oral administration offers convenience advantages over injectable peptides , but cardiovascular monitoring remains essential throughout treatment
Retatrutide SLU-PP-332 is a novel small molecule and a potent pan-agonist of the estrogen-related receptors (ERR, ERR, and ERR), which are key regulators of energy metabolism and mitochondrial function
This overlap makes B12 deficiency easy to miss during GLP-1 therapy, because both the patient and the prescriber attribute these symptoms to the medication itself rather than investigating a correctable nutritional deficit
Current Pharmaceutical Design, 24(18), 1947-1956
The trials included both single-dose pharmacokinetic studies and long-term treatment protocols extending up to 24 weeks